Huadong Medicine 华东医药
5 significant filings since 1 Jun 2026: 4 on dividend and 1 on pledge released. The latest, on 11 Sep 2026: 2026年半年度权益分派实施公告. 1 unverified report logged, the latest on 20 Aug 2026.
自 1 Jun 2026 起有 5 份重大公告：dividend 4 份、pledge released 1 份。最新一份（11 Sep 2026）：2026年半年度权益分派实施公告。记录了 1 条未经核实的报道，最新一条见于 20 Aug 2026。
Price History 价格走势
250 trading days 个交易日 · High 最高 ¥42.17 · Low 最低 ¥25.80The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 16 Nov 2023 | 上海证券 | 王盼,王真真,梁瑞 | Outperform 增持 | ▲ | Buy 买入 |
| 17 Aug 2023 | 东莞证券 | 谭欣欣 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 国金证券 | 甘坛焕,马居东 | Buy 买入 | 1 Sep 2026 | 3 | — |
| 西南证券 | 杜向阳 | Buy 买入 | 1 Sep 2026 | 1 | — |
| 长城国瑞证券 | 胡晨曦 | Buy 买入 | 14 May 2026 | 1 | — |
| 东吴证券 | 朱国广,冉胜男 | Buy 买入 | 30 Apr 2026 | 1 | — |
| 开源证券 | 余汝意,刘艺 | Buy 买入 | 28 Apr 2026 | 2 | — |
| 群益证券 | 王睿哲 | Outperform 增持 | 28 Oct 2025 | 1 | 50.00 |
Each row is a broker's latest report in the last twelve months. A price target is given in 1 of 9 reports. 每行为该券商近十二个月的最新研报；9 份中 1 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。